Cover image of the article: Therapeutic effects of fludarabine-cyclophosphamide combined therapy in Iranian patients with B-cell chronic lymphocytic leukemia

Image Credit:Koomesh

Therapeutic effects of fludarabine-cyclophosphamide combined therapy in Iranian patients with B-cell chronic lymphocytic leukemia

Authors

Kamran Moshfeghi, Dr Ghasem MosayebiDr Ghasem Mosayebi ORCID,*
*Corresponding Author: Email: gmosayebi@yahoo.com

Koomesh:Vol. 16, issue 2; 202-206
Published online:Sep 28, 2015
Article type:Research Article
Received:Feb 01, 2014
Accepted:Jul 09, 2014
How to Cite:Moshfeghi K, Mosayebi DG. Therapeutic effects of fludarabine-cyclophosphamide combined therapy in Iranian patients with B-cell chronic lymphocytic leukemia. koomesh. 2015;16(2):e151299. doi:

Abstract

 Introduction: The aim of this study was to investigate the efficacy of fludarabine-cyclophosphamide combination in treatment of Iranian patients with B-cell chronic lymphocytic leukemia (B-CLL). Materials and Methods: Between April 2011 and July 2013, 20 patients with B-CLL (median age 63 years) received a regimen that consisted of fludarabine 25 mg/m2 and cyclophosphamide 250 mg/m2, days 1-3, orally, every 4 weeks, for a maximum of 6 courses. Clinical appearances and percentage of CD5+/CD19+ cells as minimal residual disease detected by flow cytometry before and 6 months after treatment. Results: The frequency of CD5+, CD5+/CD19+ and CD19+-cells were significantly high (70-90 %) in the peripheral blood of all the patients, before treatment. The percentage of CD2 and CD3+-cells were significantly increased after treatment (p

Highlights

Copyright

© 2015, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Apr
2015
Cholorambucil versus Cholorambucil Plus Prednisolone as First-Line Therapy of Chronic Lymphocytic Leukemia in West of Iran

Cholorambucil versus Cholorambucil Plus Prednisolone as First-Line Therapy of Chronic Lymphocytic Leukemia in West of Iran

Mehrdad Payandeh,
Masoud Sadeghi,
Edris Sadeghi

Payandeh M, Sadeghi M, Sadeghi E. Cholorambucil versus Cholorambucil Plus Prednisolone as First-Line Therapy of Chronic Lymphocytic Leukemia in West of Iran. Int J Cancer Manag. 2015;8(2):e80597. doi:

2
Aug
2021
Effect of IL-27 on activity of bone marrow NK cells of patient with B-chronic lymphocytic leukemia in vitro

Effect of IL-27 on activity of bone marrow NK cells of patient with B-chronic lymphocytic leukemia in vitro

Abdolvahid Sadeghnejad,
Maral Hemati,
Mehrnoosh Pashaei,
Zahra Rasouli Nejad,
Farahnaz Ghahremanfard,
Parviz Kokhaei

Sadeghnejad A, Hemati M, Pashaei M, Rasouli Nejad Z, Ghahremanfard F, et al. Effect of IL-27 on activity of bone marrow NK cells of patient with B-chronic lymphocytic leukemia in vitro. koomesh. 2021;23(1):e153248. doi:

31
Mar
2023
Immunophenotyping of Childhood Acute Lymphoblastic Leukemia in Qazvin City, Iran: A Cross-Sectional Study

Immunophenotyping of Childhood Acute Lymphoblastic Leukemia in Qazvin City, Iran: A Cross-Sectional Study

Majid Vafaie,
Hamid Sadeghi,
Hamid Sadeghi,
Saeideh Gholamzadeh Khoei

Vafaie M, Sadeghi H, Sadeghi H, Gholamzadeh Khoei S. Immunophenotyping of Childhood Acute Lymphoblastic Leukemia in Qazvin City, Iran: A Cross-Sectional Study. J Inflamm Dis. 2024;26(4):e156328. doi:

30
Sep
2012
Outcome of Adult Acute Lymphoblastic Leukemia in South East of Iran (Zahedan)

Outcome of Adult Acute Lymphoblastic Leukemia in South East of Iran (Zahedan)

Mohammad Ali Mashhadi,
Mohhamad Mahdi Koushyar,
Mehdi Mohammadi

Mashhadi MA, Koushyar MM, Mohammadi M. Outcome of Adult Acute Lymphoblastic Leukemia in South East of Iran (Zahedan). Int J Cancer Manag. 2012;5(3):e80814. doi:

13
Mar
2016
Somatic Mutation in Immunoglobulin Gene Variable Region in Patients With Chronic Lymphoid Leukemia and Its Influence on Disease Prognosis

Somatic Mutation in Immunoglobulin Gene Variable Region in Patients With Chronic Lymphoid Leukemia and Its Influence on Disease Prognosis

Sanambar Sadighi,
Issa Jahanzad,
Mohammad Ali Mohagheghi,
Mahdieh Shokrollahi Barough,
Mohammad Hojjat-Farsangi,
Kazem Zendehdel
,et al.

Sadighi S, Jahanzad I, Mohagheghi MA, Shokrollahi Barough M, Hojjat-Farsangi M, et al. Somatic Mutation in Immunoglobulin Gene Variable Region in Patients With Chronic Lymphoid Leukemia and Its Influence on Disease Prognosis. Middle East J Rehabil Health Stud. 2016;3(2):e35848. doi: https://doi.org/10.17795/mejrh-35848

More by these authors

Kamran MoshfeghiPubMedScholar
Dr Ghasem MosayebiPubMedScholar
Share
Cited by
Metrics